UPenn gene therapy pioneer’s biotech gets $34 million in funding
A company founded by a University of Pennsylvania gene therapy pioneer announced Monday it has received $34 million in seed funding. GEMMA Biotherapeutics, founded by Jim Wilson earlier this year, focuses on developing gene therapies for rare diseases. …